B2M and neoplasm: Furthermore, CAR-T cells generated by deleting <i>TRAC</i> or <i>B2M</i> using CRISPR-Cas3 maintained their antigen-specific cytotoxicity against tumor cells, while exhibiting reduced alloreactivity.